From 29 January – 1 February 2018 the TBVI symposium and TBVAC2020 annual meeting took place in Les Diablerets, Switzerland. This yearly event was attended by over 140 participants from 70 [...]
This is to alert you on the fact that the WHO New Tuberculosis Vaccines Preferred Product Characteristics document is available on-line for public review through the following link:
The Joint Programming Initiative on Antimicrobial Resistance (JPI AMR) published a call that offers opportunities for our partners: “Innovations against antibiotic-resistant bacteria: new [...]
The Stop TB Partnership Working Group on New TB Vaccines has launched a new website offering a broad range of resources on TB vaccine development. The website provides essential background [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
